Ownership Summary
Addex Therapeutics Ltd. (NASDAQ:ADXN) currently has 1 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
- The collective stake of institutional investors in Addex Therapeutics moved to 0.0% in December 2025, a shift down from the 0.0% reported for September 2025.
- On a quarter-over-quarter basis, institutional holdings shifted by -33.06%, with a year-over-year a decrease of 83.33% in the count of filers.
- Among the 1 institutional holders of Addex Therapeutics, 0 added to their stakes while 1 trimmed their positions and 0 held steady.
- Collectively, institutional investors decreased their stake in Addex Therapeutics to 81 shares as of December 2025, a change that is down by 40 shares quarter on quarter and down 15.02K shares year over year.
- As of December 31, 2025, GAMMA Investing LLC held Addex Therapeutics's largest shareholding position with over 81 shares, representing 0.00% of total outstanding shares.
- Leading sellers of Addex Therapeutics stock in December 2025 included GAMMA Investing LLC (40).
- The top 1 institutional holders of Addex Therapeutics for the quarter ending December 2025 included GAMMA Investing LLC (81).